Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03128827 · ClinicalTrials.gov registry record · NA

Use of Rainbow Acoustic Monitoring in Pediatric Patients - A Clinical Engineering Data Collection Protocol

A NA study, sponsored by Masimo Corporation.

Completed
Registry status
NA
Development phase
170
Enrollment target

NCT03128827: Completed NA study, sponsored by Masimo Corporation.

NCT03128827 is a NA study that has completed, run by Masimo Corporation. The registered enrollment target is 170 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03128827, a NA study, has completed, sponsored by Masimo Corporation.

COMPLETED
Registry status
NA
Development phase
170 participants
Enrollment target

Study Summary

The study will capture high resolution waveform data and numerical data from three respiratory rate methods: end tidal CO2, impedance pneumography, and bioacoustic sensing (Rainbow Acoustic Monitoring, RAM).

Primary Outcome

Accuracy will be determined by comparing the noninvasive respiratory rate measurement of the sensor to that obtained from a reference and calculating the arithmetic root mean square (Arms) error value.

Interventions

  • DEVICE RAM sensor

Trial Details

FieldValue
Enrollment Target 170 participants
Start Date 2011-08-04
Est. Completion 2015-07-24
Phase NA
Masimo Corporation

96 total trials

What the finished NCT03128827 record still lists

NCT03128827 is an interventional study that assigns participants to a tested intervention. The registered 170 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower).

The record links to 0 conditions, and to 1 intervention - of which RAM sensor is the first listed.

NCT03128827 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03128827 about?

NCT03128827 is a clinical study titled "Use of Rainbow Acoustic Monitoring in Pediatric Patients - A Clinical Engineering Data Collection Protocol". The study will capture high resolution waveform data and numerical data from three respiratory rate methods: end tidal CO2, impedance pneumography, and bioacoustic sensing (Rainbow Acoustic Monitoring, RAM).

What is the current status of trial NCT03128827?

This trial is currently completed. It is a NA study. The enrollment target is 170 participants. The study started on 2011-08-04. Estimated completion is 2015-07-24.

What interventions are being tested in trial NCT03128827?

The interventions under investigation include: RAM sensor (DEVICE).

Who is sponsoring clinical trial NCT03128827?

This trial is sponsored by Masimo Corporation, which has 96 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03128827's enrollment target sits among peer trials

170 614th of 2000 higher than 1,382 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02016430 · 170 participants · NA

    Gut Flora Metabolite Reduction After Dietary Intervention (GRADY)

  • NCT02621021 · 170 participants · Phase 2

    A Phase 2 Trial for Metastatic Melanoma Using Adoptive Cell Therapy With Tumor Infiltrating Lymphocytes Plus IL-2 Either Alone or Following the Administration of Pembrolizumab

  • NCT04094701 · 170 participants · NA

    Hip Arthroscopy Postoperative Opioid Demands

  • NCT04166409 · 170 participants · Phase 3

    A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03128827, the US trial registry maintained by the National Library of Medicine. NCT03128827 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.